akhatri

/akhatri

About akhatri

This author has not yet filled in any details.
So far akhatri has created 115 blog entries.

Medicine Supply Notification: Voltarol® Ophtha and Voltarol® Ophtha Multidose eye drops

Department of Health and Social Care (DHSC) has issued a medicine supply notification for: Diclofenac (Voltarol® Ophtha) 0.1% eye drops 0.3ml unit dose preservative-free and; Diclofenac (Voltarol® Ophtha Multidose) 0.1% eye drops MSN/2026/034 Tier 2 – medium impact Date of issue: 30 July 2026 Various brands and strengths of nifedipine modified-release tablets are experiencing supply [...]

The post Medicine Supply Notification: Voltarol® Ophtha and Voltarol® Ophtha Multidose eye drops appeared first on Community Pharmacy England.

By |July 30th, 2026|Lexpos News|Comments Off on Medicine Supply Notification: Voltarol® Ophtha and Voltarol® Ophtha Multidose eye drops

Medicine Supply Notification: Nifedipine 10mg, 20mg, 30mg and 60mg modified-release tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Nifedipine 10mg, 20mg, 30mg and 60mg modified-release tablets. MSN/2026/033 Tier 2 – medium impact Date of issue: 23 July 2026 Various brands and strengths of nifedipine modified-release tablets are experiencing supply issues: Tensipine® MR 10 and 20 tablets will be out [...]

The post Medicine Supply Notification: Nifedipine 10mg, 20mg, 30mg and 60mg modified-release tablets appeared first on Community Pharmacy England.

By |July 23rd, 2026|Lexpos News|Comments Off on Medicine Supply Notification: Nifedipine 10mg, 20mg, 30mg and 60mg modified-release tablets

MHRA Drug Safety Update: Domperidone new contraindication

MHRA Drug Safety Update: Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension. The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), due to the risk of episodes of severe hypertension. [...]

The post MHRA Drug Safety Update: Domperidone new contraindication appeared first on Community Pharmacy England.

By |July 21st, 2026|Lexpos News|Comments Off on MHRA Drug Safety Update: Domperidone new contraindication

MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Martindale Pharma)

MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Macarthys Laboratories Ltd T/A Martindale Pharma) Drug alert number: EL(26)A/35 Date issued: 20 July 2026 Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in [...]

The post MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Martindale Pharma) appeared first on Community Pharmacy England.

By |July 20th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Martindale Pharma)

MHRA Class 2 Medicines Recall: ChloraPrep 1mL applicator (Beckton Dickson UK Ltd)

MHRA Class 2 Medicines Recall: ChloraPrep 1mL applicator (Beckton Dickson UK Ltd) Drug alert number: EL(26)A/34 Date issued: 13 July 2026 Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% w/v / 70% v/v cutaneous solution 1mL applicators due to a potential breach of sterility in the packaging process. DMRC reference number: DMRC-40102707 Company name: [...]

The post MHRA Class 2 Medicines Recall: ChloraPrep 1mL applicator (Beckton Dickson UK Ltd) appeared first on Community Pharmacy England.

By |July 13th, 2026|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: ChloraPrep 1mL applicator (Beckton Dickson UK Ltd)